Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06627738

Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
42 (estimated)
Sponsor
Centre Antoine Lacassagne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a monocentric, non-randomized, open-label, superiority phase II clinical investigation evaluating the efficacy of additional Cyberknife irradiation after a doublet of Platinum Salts-based chemotherapy and concomitant radiotherapy in patients with locally advanced non-small cell lung carcinoma (NSCLC), with an interim analysis.

Conditions

Interventions

TypeNameDescription
RADIATIONCyberknife irradiationAdditional Cyberknife irradiation after a doublet of Platinum Salts-based chemotherapy and concomitant radiotherapy in inoperable patients with locally advanced non-small cell lung carcinoma

Timeline

Start date
2025-06-10
Primary completion
2034-02-01
Completion
2034-02-01
First posted
2024-10-04
Last updated
2026-01-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06627738. Inclusion in this directory is not an endorsement.